Abstract:Background: percutaneous coronary intervention (PCI) has become the mainstay of treatment for atherosclerotic cardiovascular disease (ASCVD). Inflammatory factors have been shown to be involved in the initiation and progression of ASCVD. After PCI, the persistence of inflammation, especially the inflammation released at the target lesion, may affect the stability of non-target lesion plaques. Interleukin-6 (IL-6) is one of the most common inflammatory factors, however studies about the influence of IL-6 on the progression of non-target lesions (NTLs) of coronary artery are limited. This study investigated whether serum IL-6 levels can affect the progression of NTLs after coronary stent implantation. Methods: We performed a retrospective cohort study including 441 patients undergoing coronary angiography (CAG) and stent implantation, who had at least one NTL, between January 2019 and December 2021. They underwent followup CAG 9 to 12 months after PCI. Quartile grouping was based on serum IL-6 levels following readmission. The relationship between serum IL-6 levels and the progression of NTLs after coronary stent implantation was analyzed by using logistic regression analysis and restricted cubic spline regression. Predictive value of IL-6 on NTL progression was evaluated using the receiver operating characteristic (ROC) curve. Results: When compared to the first quartile (Q1) group, the probability of NTL progression was increased in Q2 (adjusted odds ratio (aOR) 3.06, 95% CI 1.29-7.29), Q3 (aOR 3.55, 95% CI 1.52-8.26), and Q4 group (aOR 7.51, 95% CI 3.30-17.05), with a trend test p < 0.001. With the increase of IL-6 levels, the risk of progression of NTLs gradually increased, and there was a non-linear relationship between IL-6 and progression of NTLs (p < 0.001). The ROC curve showed that the critical value of the serum IL-6 level was 12.652 pg/mL (area under the curve is 0.673, sensitivity is 54.5%, specificity is 70.9%, p < 0.05). Conclusions: A high serum IL-6 level is an independent risk factor for the progression of NTLs after coronary stent implantation, and has certain predictive value for the progression of NTLs.

Alteration of Serum Interleukin-6 and Tumor Necrosis Factor-Α after Ischemic Stimulation of Coronary Artery in PTCA

The Change and Clinical Significance of Serum Tumor Necrosis Factor-Α、interleukin-6 and Interleukin-8 after Cutting Balloon Angioplasty and Stent Implantation

Impacts of Atherosclerotic Plaque Composition and Platelet Aggregation on Serum Cardiactroponin T Elevation after Percutaneous Coronary Interventions

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

Impact Of Increased Inflammation Biomarkers On Periprocedural Myocardial Infarction In Patients Undergoing Elective Percutaneous Coronary Intervention: A Cohort Study

The Influence of Emergency Percutaneous Coronary Intervention on Plasma Cytokines in Acute Myocardial Infarction

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

Serum levels of tumor necrosis factor-α and interleukin-6 after SafeCutTM angioplasty and stent implantation and their clinical significance

Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty

Effects of Percutaneous Transluminal Coronary Angioplasty on Serum Soluble Intercellular Adhesion Molecule-1 and P-selectin Levels

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction

[Temporal changes and interaction of serum cytokines in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention].

Effect of percutaneous intervention on adrenomedullin and tumor necrosis factor in the coronary circulation]

Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 Through Late Preconditioning in Unstable Angina Patients

[Relation Between Inflammation Related Cytokines and Myocardial Microcirculatory Reperfusion State].

Study on the heart release kinetics of endothelin after percutaneous transluminal coronary angioplasty(PTCA)

Minor myocardial injury and it's clinical effects after percutaneous transluminal coronary angioplasty with or without stenting

Effect of Serum IL-6 Levels on the Progression of Non-Target Lesions in Patients after Coronary Stenting

Changes of Plasma Soluble P-selectin, TNF-α and IL-6 in Patients with Acute Myocardial Infarction and Effects of Early Reperfusion Therapy on Them

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].